HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.

Abstract
We report the in vivo evaluation, in a murine model, of MRI measurements of the extracellular volume fraction (ECV) for the detection and monitoring of systemic amyloidosis. A new inducible transgenic model was used, with increased production of mouse serum amyloid A protein controlled by oral administration of doxycycline, that causes both the usual hepatic and splenic amyloidosis and also cardiac deposits. ECV was measured in vivo by equilibrium contrast MRI in the heart and liver of 11 amyloidotic and 10 control mice. There was no difference in the cardiac function between groups, but ECV was significantly increased in the heart, mean (standard deviation) 0.20 (0.05) versus 0.14 (0.04), p < 0.005, and liver, 0.27 (0.04) versus 0.15 (0.04), p < 0.0005, of amyloidotic animals and was strongly correlated with the histological amyloid score, myocardium, ρ = 0.67, p < 0.01; liver, ρ = 0.87, p < 0.01. In a further four mice that received human serum amyloid P component (SAP) followed by anti-human SAP antibody, a treatment to eliminate visceral amyloid deposits, ECV in the liver and spleen returned to baseline after therapy (p < 0.01). MRI measurement of ECV is a sensitive marker of amyloid deposits with potential application for early detection and monitoring therapies promoting their clearance.
AuthorsAdrienne E Campbell-Washburn, Anthony N Price, Stephan Ellmerich, J Paul Simons, Raya Al-Shawi, Tammy L Kalber, Rupinder Ghatrora, Philip N Hawkins, James C Moon, Roger J Ordidge, Mark B Pepys, Mark F Lythgoe
JournalAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (Amyloid) Vol. 20 Issue 2 Pg. 93-8 (Jun 2013) ISSN: 1744-2818 [Electronic] England
PMID23621497 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid
  • Serum Amyloid A Protein
  • Serum Amyloid P-Component
Topics
  • Amyloid (metabolism)
  • Amyloidosis (diagnosis, metabolism, pathology)
  • Animals
  • Extracellular Fluid (metabolism)
  • Female
  • Humans
  • Liver (diagnostic imaging, metabolism, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Mice
  • Mice, Transgenic
  • Myocardium (metabolism, pathology)
  • Radiography
  • Serum Amyloid A Protein (metabolism)
  • Serum Amyloid P-Component (immunology, metabolism)
  • Spleen (diagnostic imaging, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: